A recent report published by Infinium Global Research on antacids market provides in-depth analysis of segments and sub-segments in global as well as regional antacids market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional antacids market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global antacids market. According to the report the global antacids market is projected to grow at a CAGR of 4% over the forecast period of 2018-2024. It was worth USD 4.50 billion and it is anticipated to surpass USD 9.0 billion by 2024.
An antacid is a substance that neutralizes stomach acidity and it is used to relieve the body from indigestion and upset stomach. When excessive amounts of acids are produced in the stomach the natural mucous barrier that protects the stomach can damage the esophagus with acid. Combination of aluminum-magnesium antacids are less likely to cause constipation or diarrhea they are only aluminum or only magnesium antacids. They can also be used to relieve the pain of the stomach and ulcers some antacids contain simethicone which reduces gas. The report defines the antacid market as drug classes such as Disease Modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, and Uric Acid Drugs among Others sold through the various distribution channels such as Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. These antacids are served in the form of tablet, liquid, and powder.
Increasing geriatric population around the world is the major driving factor responsible for the growth of the antacids market. According to data from World Population Prospects 2017, the number of older persons those aged 60 years or over are 962 million globally in 2017 comprising about 13 %of the global population, which is expected to be more than double accounting for nearly 1.5 billion by the end of 2030. Additionally, the intake of medication for other medical conditions, which are associated with acid reflux and excess acid production also accounts for significant demand for antacids among this population. On the other hand, the rising popularity of e-commerce and surge in the number of online medicine providers are estimated to positively influence the expansion of the market. Moreover, the restraints that are likely to hamper the growth in the antacids market include side effects associated with these antacids such as constipation, laxative effect, and allergic reactions.
North America is expected to be the largest region for the antacid market followed by the Asia Pacific by 2024. Currently, due to the drastic change in the dietary habits of people, North America is the largest dominating region. Moreover, Asia Pacific is an emerging market for antacid due to the increase in the aging population. China and India are key domestic markets in the region due to the improvement of healthcare services. The key players in the antacid market include Johnson & Johnson, Pfizer Inc and Sanofi. Johnson & Johnson-Merck's Mylanta is the number one antacid in the U.S. market following a 25% sales gain. Sanofi, the French pharmaceutical company, has agreed to accept Johnson & Johnson's Rolaids antacid medicine as part of its momentum into the growing consumer healthcare market. Sanofi identified consumer healthcare as a core growth platform for the company and subsequently acquired Chattanooga, Tennessee-based Chattem in March 2010. The acquisition of Chattem provided Sanofi with a presence in the U.S. consumer healthcare market.
The report on global antacids market covers segments such as, by drug class, by formulation and by distribution channel. On the basis of by drug class, the global antacids market is categorized into proton pump inhibitor, H2 antagonist and acid neutralizers. On the basis of formulation, the global antacids market is categorized into tablet, liquid, and powder. On the basis of by distribution channel, the global antacids market is categorized into hospital pharmacy, retail pharmacy, and online pharmacy.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography is provided over the period of 2016-2024.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global antacids market such as WellSpring Pharm, Private Lable, GSK, Johnson & Johnson, Novartis Consumer Health, Boehringer Ingelheim Pharm, GlaxoSmithKline, Procter & Gamble, Pfizer, and First Aid Only.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global antacids market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of antacids market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the antacids market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the antacids market to understand the present and future trends in this market and formulate their strategies accordingly.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter